Xcout Intel
Nimbus Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Nimbus Therapeutics among biotech companies — ranked by similarity to what Nimbus Therapeutics actually does, not by market-cap band.
Subscribe to see Nimbus Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Nimbus Therapeutics
Nimbus Therapeutics is a biotechnology company that uses structure-based drug discovery and computational chemistry to develop small-molecule medicines. It focuses on therapeutic areas including oncology, autoimmune disease, and metabolic disorders, serving patients through internally developed programs and pharmaceutical partnerships.
Nimbus Therapeutics at a glance
Nimbus Therapeutics is a biotech company. It has raised at least $252M across the 4 funding rounds on record. Its most recent funding round, Growth, raised $125M in September 2022. Xcout tracks 11 named people at Nimbus Therapeutics, including Abbas Kazimi (Chief Executive Officer). Xcout recorded 2 job postings from Nimbus Therapeutics in the last 90 days.
Nimbus Therapeutics leadership
- Abbas KazimiChief Executive Officer
- Peter J. TumminoPresident of Research & Development
- Ian SandersonChief Financial Officer
- Anita ScheuberSenior Vice President, Therapeutic Area Head, Oncology
- Fang WangSenior Vice President, Biology
- Scott EdmondsonSenior Vice President, Chemistry
5 more named people on record for Nimbus Therapeutics, with roles, board committees and tenure — see the full roster →
Nimbus Therapeutics funding rounds
At least $252M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $125M | — | |
| Growth | $60M | — | |
| Series B | $43M | 2 named | |
| Series A | $24M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Nimbus Therapeutics
Xcout recorded 2 job postings from Nimbus Therapeutics in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Nimbus Therapeutics's hiring signals →
Top 12 Nimbus Therapeutics competitors
Ranked by semantic similarity — how close each company is to Nimbus Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Biotechnology
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Similar biotech company
Ditto Biosciences is a company headquartered in San Francisco, US, that focuses on drug discovery. The company is involved in identifying proteins that could lead to new drugs for patients with autoimmune diseases.
Biotechnology
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
Similar biotech company
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Similar biotech company
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Similar biotech company
Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.
Biotechnology
Parabilis Medicines is a biopharmaceutical company that develops ultra-tunable peptide therapeutics utilizing its proprietary Helicon platform. The company focuses on creating novel medicines to target historically undruggable conditions, primarily addressing cancer and other serious diseases with critical medical needs.
Similar biotech company
Atavistik Bio is a U.S. biotechnology company developing small-molecule medicines by targeting allosteric sites and metabolite-regulated biology, using its chemoproteomics and drug-discovery platform. Its programs are aimed at treating cancer and other serious diseases.
Similar biotech company
Schrödinger, Inc. develops physics-based computational software and technology platforms for drug discovery and materials science. It serves pharmaceutical and biotechnology companies, academic institutions, and research organizations, and also applies its platform through internal drug-discovery programs.
Similar biotech company
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Biotechnology
Hummingbird Bioscience Holdings Limited is a clinical-stage biotechnology company that utilizes a proprietary Rational Antibody Discovery (RAD) platform and integrates artificial intelligence with experimental science. The company focuses on developing a pipeline of precision biotherapeutics and transformative medicines targeting hard-to-drug targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Nimbus Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Nimbus Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →